Berberine vs Metformin: A Supplement and a Medicine

Metformin went through the FDA's drug-approval process, and its label is the FDA-approved account of what it is used for, what it can do wrong and how to monitor it. At ACT 2 it is dispensed as manufactured.

Berberine reaches the shelf by a different route. Under the law that governs dietary supplements, the FDA does not have the authority to approve supplements before they are marketed, and a company generally does not have to show the FDA its evidence of safety first. The American Academy of Family Physicians notes that, as with all supplements, it is impossible to know for sure whether the ingredients listed on the bottle accurately represent what is inside. The Department of Defense's Operation Supplement Safety program makes the same point: without laboratory testing, there is no way to know a product's actual ingredients or their amounts, and it suggests checking whether a product has been evaluated by an independent third-party organization.

That difference matters more than any single study. Even if berberine's effects were well established, a buyer would still not know how much of it a given capsule contains.

Metformin. MedlinePlus describes metformin as used alone or with other medicines, including insulin, to treat type 2 diabetes. It has a long record of use, and ACT 2 considers it for eligible adults where insulin resistance is part of the picture, including prediabetes. Using it outside an approved indication is off-label and decided case by case.

Berberine. There is a body of research, but its quality is limited. A 2025 meta-analysis of randomized placebo-controlled trials in metabolic syndrome found berberine lowered fasting glucose, triglycerides and waist circumference compared with placebo, and found no significant effect on blood pressure or HDL cholesterol. A 2025 overview of fifty-four systematic reviews of berberine found most of them were of low or very low methodological quality, and its authors urged caution. The AAFP's assessment is that rigorous data demonstrating benefit are lacking.

Those two descriptions are not a head-to-head comparison, and neither should be read as one.

Metformin. MedlinePlus says your doctor will order tests before and during treatment to check how well your kidneys are working and how you respond. The label's most serious warning is lactic acidosis, a rare but dangerous build-up of acid in the blood; the risk rises with kidney or liver problems, heavy drinking, contrast imaging, surgery and some other medicines.

Metformin and vitamin B12. The Glucophage label reports that metformin can lower vitamin B12 levels, possibly by interfering with its absorption, and advises checking blood counts every year. It adds that people with low B12 or calcium intake or absorption seem more prone to low levels and may benefit from periodic B12 measurement. Low B12 symptoms are easy to mistake for aging, which is why it is worth checking. B12 and other medications explains which drugs lower it, and the B12 injection page covers one way it is replaced.

Berberine. There is no standard monitoring schedule for a supplement. Operation Supplement Safety lists diarrhea, constipation, nausea and stomach upset as the common side effects, says long-term safety data are lacking, and advises against it in pregnancy and breastfeeding. Tell your clinician if you take it, especially alongside prescribed medicines.

The AAFP notes that berberine has multiple known interactions with medicines processed by the liver, including metformin itself. That makes "berberine and metformin together" a question for your clinician, not something to try on your own; combining two things that both act on blood sugar also complicates reading your results.

The metformin label lists its own interaction risks. Carbonic anhydrase inhibitors such as topiramate raise the risk of lactic acidosis, and the label says metformin may need to be stopped around imaging studies that use iodinated contrast dye. Alcohol, particularly heavy or binge drinking, raises the risk of lactic acidosis and of low blood sugar. Bring a full list of your medicines and supplements to your assessment.

Metformin at ACT 2 is $99 a month. Lab work, including the tests used to monitor it, is priced separately; see pricing. ACT 2 does not prescribe or sell berberine, and supplement prices vary by brand and store, so there is no figure to compare. A lower price on a bottle does not buy a known amount of the active ingredient.

If your concern is weight rather than blood sugar, metformin is not a weight-loss drug, and the medical weight loss page covers the options. If your labs show diabetes, your treatment needs a clinician's plan, not a supplement. For women in the menopause transition with a history of PCOS or gestational diabetes, metformin in perimenopause is the more specific read. And if stomach side effects are what put you off metformin before, the extended-release vs immediate-release page covers the formulation question.